Rapport Therapeutics, Inc. ($RAPP)
Total Shares
61,694
Total Value
$1,664,824.34
Avg P&L
-7.2%
Timeframe
2 days
Nearby Earnings
Nov 5, 2026
EPS:Est: -1.20
Participants
| Name | Title | Security | Derivative | Filing Date | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Oct 21, 2026 | Oct 21, 2026 | P | 5,500 | $26.10 | $143,550.00 | 15,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 22, 2026 | Oct 22, 2026 | P | 1,172 | $26.92 | $31,547.08 | 9,411 | Indirect | By John M. Maraganore Revocable Trust | View Details | |
Director | Common Stock | โ | Oct 22, 2026 | Oct 22, 2026 | P | 8,239 | $26.38 | $217,344.00 | 8,239 | Indirect | By John M. Maraganore Revocable Trust | View Details | |
Director | Common Stock | โ | Oct 22, 2026 | Oct 22, 2026 | P | 35,714 | $27.28 | $974,277.92 | 77,380 | Indirect | By Paul Capital Strategy III Fund LLC | View Details | |
Director | Common Stock | โ | Oct 22, 2026 | Oct 22, 2026 | P | 3,680 | $27.07 | $99,636.00 | 3,680 | Indirect | By Paul M Silva 2016 Declaration of Trust U/A DTD 12/19/2016 | View Details | |
Director | Common Stock | โ | Oct 22, 2026 | Oct 22, 2026 | P | 3,789 | $26.39 | $99,991.71 | 13,289 | Direct | โ | View Details | |
Director | Common Stock | โ | Oct 23, 2026 | Oct 23, 2026 | P | 3,600 | $27.35 | $98,477.64 | 3,600 | Direct | โ | View Details |